Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 460)
Posted On: 11/10/2020 11:17:43 PM
Post# of 36566
Posted By: Paul Jackson
Posted by Rich Purcell on LinkedIn

“Wow - people are finally realizing the importance of the T Cell response for long term immune memory. NuGenerex Immuno-Oncology a subsidiary of Generex Biotechnology (GNBT) is developing a COVID vaccine that is designed to activate the T Cell and B Cell (antibody) response for a Complete Vaccine - go to NuGenerexio.com - r

#covid #generex #vaccine #SARS-CoV- 2
#completevaccine”

https://www.nytimes.com/2020/11/10/health/t-c...unity.html













(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site